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Abstract. The thermal behaviour of a Pt(IV) and a Ru(II) complex coordinated 
to dibutyl (S,S)-α,α′-(1,2-ethanediyldiimino)biscyclohexanepropanoate was 
investigated using thermogravimetry (TG) and differential scanning calorim-
etry (DSC). The study included an investigation of the thermal decomposition 
of these complexes in the temperature range of 30 to 590 °C and an evaluation 
of the activation energy for the first decomposition steps. For both metal 
complexes, broad DSC peaks indicated complex thermal transformation pro-
cesses. The two-step decomposition of the Pt(IV) complex started at 175 and 
ended at about 418 °C, leaving elemental platinum as the final residue. On the 
other hand, the Ru(II) analogue decomposed in three stages. Thermal degrad-
ation was evident beginning at 144 °C and suggested the decomposition of a 
coordinated ligand as the dominant process. For this complex, the proposed 
final residue was RuO2. Kinetic parameters for the first decomposition step 
were obtained by means of the multi-heating rates method, in this case the 
Kissinger–Akahira–Sunose (KAS) method. The mean activation energy calcul-
ated for 0.2 < α < 0.8 were 122.0 kJ mol-1 for the Pt(IV) and 118.9 kJ mol-1 for 
the Ru(II) complex and decreased constantly, a characteristic of a multi-step 
process. 
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INTRODUCTION 
The field of metal-containing drugs was established by Rosenberg’s revol-
utionary discovery of cisplatin in the late 1960s.1,2 Despite its benefits in clinical 
treatment, cisplatin displayed significant side effects3,4 that could not be neg-
lected. Numerous platinum as well as ruthenium, palladium, gold and even 
osmium complexes have been synthesized in the past decades5−9 but therapeutic 
use is still limited to only a few of them (carboplatin, oxaliplatin, NAMI-A, 
KP1019).10−12 In this sense, platinum- and ruthenium-based drugs are dominant 
compounds in the field of bioinorganic chemistry considering their cytotoxicity 
and determined mechanism of action.13 Modern studies commonly include syn-
thetic procedures and characterization of novel compounds followed by examin-
ation of their redox properties and interaction with biomolecules under physio-
logical conditions.14,15 Hitherto, only a few studies have included detailed exam-
ination of the thermal behaviour of the complexes.16–18 Primarily, investigation 
of the thermal behaviour of various metal complexes was performed in order to 
link metal–ligand bonding and their structural properties.19 In this way, it was 
possible to confirm the coordination mode of ligands and to test the stability of 
synthesized compounds at higher temperatures. Recently a few studies have sug-
gested that the thermal characterization of potential antitumor agents could be 
used as a potential method for the determination of the fate compounds in the 
human body.20−22  
The synthesis, characterization and antitumor activity of Pt(IV) and Ru(II) 
complexes bearing cyclohexyl functionalized ethylendiamine-N,N′-diacetate-type 
ligands was reported.23,24 The main advantage of complexes containing edda-
(ethylenediamine)-type ligands is their strong anticancer activity. Most of these 
complexes exhibit strong antitumor potential toward various cancer cell lines 
(U251, C6, L929, B16, A375, U251, B16 and PC3).23,24 Among all reported 
Pt(IV) and Ru(II) complexes with this type of ligand, the compounds with 
n-butyl esters of (S,S)-α,α′-(1,2-ethanediyldiimino)biscyclohexanepropanoic acid 
((S,S)-nBu2eddchxp) were the most active ones and for this reason they were sel-
ected for investigation of their thermal properties in this study. 
EXPERIMENTAL 
Measurements were performed using a thermobalance coupled with differential scanning 
calorimeter (TG-DSC 111 from Setaram, Caluire-et-Cuire, France) consisting of a quartz 
micro-reactor, heated in a vertical furnace. The experiments were performed under a dynamic 
helium atmosphere as the carrier gas (30 cm3 min-1) in the temperature range from 30 to 590 
°C at heating rates of 5, 8 and 12 °C min-1. The investigated complexes, C1, [PtCl4{(S,S)- 
-nBu2eddchxp}] and C2, [(η6-p-cymene)RuCl{(S,S)-nBu2eddchxp}]PF6 (Fig. 1), were syn-
thesized according to published procedures23,24 and characterized by infrared (IR) and nuclear 
magnetic resonance (NMR) spectroscopy. The IR spectra were recorded on a Nicolet 6700 
FT-IR spectrometer using the ATR technique. The 1H spectra were obtained using Varian 
Gemini 200 and Bruker Avance III 500 spectrometers. The samples were dissolved in deuter-
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ated dimethyl sulfoxide (DMSO-d6) with tetramethylsilane (TMS) as the reference. The 
obtained results for both compounds (Supplementary material to this paper) were in agree-
ment with previously reported data.23,24 
 
Fig. 1. Structures of the studied compounds C1, [PtCl4{(S,S)-nBu2eddchxp}], and C2, 
([(η6-p-cymene)RuCl{(S,S)-nBu2eddchxp}]PF6). 
For a preparation of complex C1, dibutyl (S,S)-α,α′-(1,2-ethanediyldiimino)biscyclo-
hexanepropanoate dihydrochloride (0.18 g, 0.41 mmol) was added to 15 mL of an aqueous 
solution of K2[PtCl6] (0.20 g, 0.41 mmol) at 80 °C. The mixture was stirred for 8 h while a 
solution of LiOH (16.5 mL, 0.19 mol dm-3) was added portion-wise. The formed precipitate 
was collected by filtration, washed with water and dried. Compound C1 was obtained as 
yellow powder.23 Yield: 52 %.  
Compound C2 was synthesized in the reaction of [(η6-p-cymene)RuCl2]2 (0.12 g, 0.20 
mmol), previously dissolved in methanol (11 mL) with a suspension of ligand dibutyl (S,S)- 
-α,α′-(1,2-ethanediyldiimino)biscyclohexanepropanoate dihydrochloride (0.22 g, 0.40 mmol) 
in methanol (10 mL) previously neutralized with LiOH·H2O (0.03 g, 0.80 mmol). The reac-
tion mixture was stirred at 40 °C for 2.5 h. After the addition of NH4PF6 (0.11 g, 0.68 mmol), 
a fine yellow–orange solid was isolated.24 Yield: 49 %. 
RESULTS AND DISCUSSION 
The main objective of this study was to analyze the thermal behaviour of the 
biologically active complexes C1 and C2. The recorded TG and DSC curves for 
complexes C1 and C2 are shown in Fig. 2. The TG and DSC parameters for the 
investigated complexes (stages of decomposition, their temperatures ranges, cor-
responding DSCmax values, transferred heat values, mass loss percentages and 
evolved moieties for each stage) are presented in Table I. 
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Fig. 2. Thermoanalytical curves of complexes C1 and C2 obtained at a heating rate 
β = 5 °C min-1 under a helium flow. 
TABLE I. TG and DSC decomposition parameters for C1 and C2 at β = 5 °C min-1 
Complex Stage Temperature range, °C 
DSCmax
°C 
∆H 
kJ kg-1 
Mass loss, % Evolved 
moiety Found Theor. 
C1 I 175–225 202 − 847.1 17.59 17.34 2HCl, 2Cl 
II 230–396 254 −1644.6 58.55 58.80 C28H50N2O4 
Residue 418–590 – – 23.26 23.85 Pt 
C2 I 114–167 153 −575.5 16.38 16.17 PF6- 
II 179–228 193 −775.4 23.98 22.64 C10H14Cl 
III 271–381 317 −1353.5 38.47 44.92 C28H52N2O2 
Residue 406–590 – – 14.39 14.84 RuO2 
Thermal analysis of complex C1 
The TG curve obtained for complex C1 (Fig. 2) indicates its thermal stability 
up to 175 °C when decomposition begins (Table I). The first step occurs in the 
temperature range from 175 to 225 °C and represents a fast mass loss (Δm = 
= 19.18 %) originating from all four chlorido ligands in the axial position. This 
assumption is primarily made based on satisfying agreement with theoretical 
mass loss value (Δm = 17.34 %) and probably originates from elimination of HCl 
and chlorido ligands. In the same temperature region, a dominant peak in DSC 
curve is observed (Fig. 2) at Tmax= 202 °C. Above 230 °C, a significant mass 
loss due to decomposition of the organic moiety occurs.25 The elimination of the 
organic ligand appears over a large temperature range (230–396 °C). Based on 
the TG curve, this process occurs in two steps. The first step appears in the tem-
perature range from 230 to 313 °C (Δm = 37.37 %), while the second occurs 
from 315 to 396 °C (Δm = 17.27 %). The sum of corresponding mass losses for 
these two steps equals mass of the whole ligand (Δm = 54.64 %) and is clearly 
assigned to the C28H52N2O4 moiety.25 The complexity of this degradation step is 
also obvious in the DSC curve. The broad, rather complex DSC peak reflects the 
multiplicity of the degradation process caused by the bulkiness of the ligands. 
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The final step occurs around 418 °C and shows mass loss of Δm = 23.26 %. This 
result clearly indicates that final residue consists of elemental platinum as the 
evaluated experimental value of the mass loss fully corresponds to the theoretical 
one (Δm = 23.85 %). The obtained results are in agreement with literature since 
platinum complexes generally decompose either to platinum carbides or elemen-
tal platinum.26,27 Taking all the given data into account, the multi-step decom-
position of C1 starts at 175 and ends around 418 °C leaving elemental platinum 
as the final residue. 
Thermal analysis of complex C2 
The TG and DSC curves obtained for complex C2 (Fig. 2) suggest that 
decomposition occurs in at least three major steps (Table I). The Ru(II) complex 
starts to decompose at 114 °C. The first step noted in the temperature range from 
114 to 167 °C shows a mass loss of 16.38 %, which indicates the loss of counter 
ion species, PF6−. This stage is also manifested in corresponding DSC curve as a 
complex peak, obviously involving two overlapping processes. The following 
two steps (II and III), corresponding to the loss of the organic part, cover the 
wide temperature range from 179 to 381 °C.28 In this part of the TG plot, total 
mass loss equals 62.45 % clearly indicating the organic ligand release. DSC 
curve is in an agreement with proposed thermal decomposition mechanism. The 
second peak is asymmetric and broad with Tmax at 193 °C. The third peak in 
DSC curve (271–381 °C) corresponds to the noticeable change in the slope of the 
plot. The largest mass loss (≈38.47 %) was detected in this temperature range 
since it probably involves decomposition of the ligand, dibutyl (S,S)-α,α′-(1,2- 
-ethanediyldiimino)biscyclohexanepropanoate. Finally, the investigated Ru(II) 
complex decomposed to RuO2 (Δm = 14.39 %). Literature data showed that com-
plex degradation of Ru compounds eventually leads to RuO2 as the final 
residue.28,29 
Solid-state kinetics and isoconversional method for the evaluation of activation 
energy 
Kinetic analyses of solid-state transformations are based on a single-step 
kinetic equation: 
 d ( ) ( )d k T ft
α
α=  (1) 
where k(T) is the rate constant, t is the time, T is the temperature, α is the 
fractional extent of reaction, and f(α) is a conversion function which depends on 
the particular reaction model. 
The temperature dependence of the rate conversion is introduced by rep-
lacing k(T) with the Arrhenius equation, which gives the relation: 
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 ( )ad expd
EA f
t RT
α
α
 
= −    (2) 
where A (the pre-exponential factor) and Ea (the activation energy) are the 
Arrhenius parameters and R is the gas constant.  
For non-isothermal measurements at constant heating rate, β, Eq. (2) trans-
forms to: 
 ( )ad expd
EA f
T RT
αβ α = −    (3) 
where dα/dt ≡ β(dα/dT). 
The great majority of detailed kinetic studies start with an evaluation of the 
activation energy values of thermal-induced processes.30−32 Generally, isocon-
versional methods can be linear (when the activation energy values are deter-
mined from the slope of a straight line) or non-linear (when the activation energy 
values are determined from a specific minimum condition).33 Within this work, 
isoconversional or “model-free” kinetic procedures were used, such as the Kis-
singer–Akahira–Sunose (KAS) integral linear method, which is based on the fol-
lowing equation:34,35 
 ( )a a2 aln ln
A R Ef
E RTTα
β
α
α
   
= − −     
 (4) 
where α is the degree of conversion and f(α) is the integral conversion function. 
Therefore, the calculations of the activation energy included determination 
of the slopes for the graph dependences ln(β/T2) vs. (1/T) and ln(β) vs. (1/T) for 
α = const. Plots of α vs. T (Fig. 3) were obtained from the experimental DSC 
curves recorded at three constant heating rates and they all refer to the first 
degradation stage defined in Table I (Fig. S-1 of the Supplementary material to 
this paper). As expected, the obtained α = f(T) plots are sigmoid-shaped36 for 
both complexes and shifted to higher temperatures with increasing heating rate, 
indicating that thermal activation steps are involved in the degradation (Fig. 3). 
The results presented in Fig. 3 were obtained using the KAS method. All the 
calculations refer to the first degradation stage. The temperature range for the 
first degradation steps for the investigated complexes are given in Table I. The 
mean values of the activation energy corresponding to the first thermal decom-
position step and determined for the conversion degree range 0.2 < α < 0.8 (step 
of a 0.05) are: Ēa (C1) = 122.0±0.5 kJ mol−1 and Ēa (C2) = 118.9±0.5 kJ mol−1. 
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Fig. 3. Fractional conversion (α) as a function of temperature (T) and apparent activation 
energies as a function of fractional conversion (α) in the range 0.2 < α < 0.8 for the KAS 
method. 
CONCLUSIONS 
The thermal behaviour of two metal complexes (Pt(IV) and Ru(II)) bearing 
the dibutyl (S,S)-α,α′-(1,2-ethanediyldiimino)biscyclohexanepropanoate ligand 
were examined over the temperature range from 30 to 590 °C. Both TG and DSC 
data indicated that the thermal decomposition of these compounds is a multi-step 
degradation process. The decomposition of the Pt(IV) complex starts at 175 °C 
and includes two steps. The first reflects the loss of HCl and chlorido ligands, 
and second corresponds to a major loss originating from the loss of the organic 
ligand. The final residue of the decomposition according to the mass loss value 
was elemental platinum. In this case, all the thermal transformations were com-
pleted below 418 °C. The Ru(II) analogue was significantly less stable than the 
Pt(IV) compound since its degradation started at 114 °C. In the first stage, the 
observed mass loss corresponds to the mass of the counter ion (PF6−). The fol-
lowing two steps involve the loss of two organic moieties, first the cymene part, 
and then the cyclohexyl part. Eventually, the Ru(II) complex fully decomposed 
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to leave RuO2 as the final residue at 406 °C. Evaluation of the isoconversional 
activation energies suggests that the decomposition of both compounds is a com-
plex process, probably involving more than one step. Overall, the degradation is 
a stepwise process as might be expected for the complex structures of the Pt(IV) 
and Ru(II) complexes. The investigated compounds are representatives of the 
edda-metallo-drug-family based on their strong antitumor activity. Thermal stab-
ility up to 100 °C was demonstrated. Therefore, the thermal stability for this type 
of compound does not represent any kind of drawback for further clinical studies. 
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The spectral data and DSC curves for C1 and C2, are available electronically 
from http://www.shd.org.rs/JSCS/, or from the corresponding author on request. 
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И З В О Д  
ЦИТОТОКСИЧНИ Pt(IV) И Ru(II) КОМПЛЕКСИ СА БИОЛОШКИ РЕЛЕВАНТНИМ 
ЕДДА-ТИПОМ ЛИГАНДА: УПОРЕДНА СТУДИЈА ЊИХОВИХ ТЕРМИЧКИХ СВОЈСТАВА 
ЉИЉАНА Е. МИХАЈЛОВИЋ-ЛАЛИЋ1, ЉИЉАНА ДАМЈАНОВИЋ2, МАЈА ШУМАР-РИСТОВИЋ3,  
АЛЕКСАНДАР САВИЋ3, ВЕРА ДОНДУР2, ТИБОР Ј. САБО3 и САЊА ГРГУРИЋ-ШИПКА3 
1Иновациони центар Хемијског факултета, Студентски трг 12–16, Београд, 2Факултет за физичку 
хемију, Универзитет у Београду, Студентски трг 12–16, Београд и 3Хемијски факултет, 
Универзитет у Београду, Студентски трг 12–16, Београд 
Термичко понашање Pt(IV) и Ru(II) комплекса координованих за дибутил-(S,S)- 
-α,α-(1,2-етандиилдиимино)бисциклохексанпропаноат је испитивано коришћењем тер-
могравиметрије (ТГ) и дифенцијалне сканирајуће калориметрије (DSC). Студија је 
обухватила испитивање термичког разлагања наведених комплекса у температурском 
опсегу од 30 до 590 °C и процену енергије активације првог корака разлагања. За оба 
метална комплекса, широки DSC максимум је указао на сложени термички процес. Дво-
степено разлагање Pt(IV) комплекса почиње на 175 и завршава се на око 418 °C остав-
љајући елементалну платину као крајњи производ. С друге стране, разлагање његовог 
Ru(II) аналогa се одвија у три ступња. Термодинамички ефекти су примећени на 144 °C 
и указали су на разлагање координованог лиганда као доминатни процес. За овај ком-
плекс, предложени крајњи остатак је RuO2. У погледу основних кинетичких израчуна-
вања, добијени су кинетички параметри првог ступња разлагања на основу Kissinger– 
–Akahira–Sunose (КАС) методе. Средње енергије активације израчунате за 0,2 < α <0,8 
износе 122,0 kJ mol-1 за Pt(IV) и 118,9 kJ mol-1 за Ru(II) комплекс и константно опадају 
описујући вишестепени процес. 
(Примљено 20. марта, ревидирано 12. маја, прихваћено 20. маја 2016) 
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